Human papillomavirus vaccination: evidence base for efficacy and safety
The article provides a literature review on the prevention of cervical cancer by human papillomavirus (HPV) vaccination. Currently, 3 vaccines are available: the 4-valent vaccine against HPV types 6, 11, 16 and 18, the 9-valent vaccine against HPV types 6, 11, 16, 18, 31, 33, 45, 52, 58 and the biva...
Guardado en:
Autores principales: | Yuliya E. Dobrokhotova, Ekaterina I. Borovkova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Berlin A.V.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3cd0860d5a44aaea2675f7a907386d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
What a patient needs to know about the virus human papillomas and cervical cancer?
por: Sergei P. Sinchikhin, et al.
Publicado: (2021) -
Cervical cancer: monitoring of the main indicators characterizing this pathology in Khabarovsk Krai (2009–2019)
por: Tatyana Yu. Pestrikova, et al.
Publicado: (2021) -
Vulvovaginitis and their correction in patients with cervical HPV-associated diseases in the light of the doctrine of pathomorphosis
por: Irina N. Kononova, et al.
Publicado: (2021) -
Comparative evaluation of the results of an immunocytochemical study of P16/Ki-67 coexpression in patients with cervical intraepithelial neoplasia associated with human papillomavirus
por: Tatiana V. Klinyshkova, et al.
Publicado: (2021) -
Correction to: Adaptation of patients diagnosed with human papillomavirus: a grounded theory study
por: Narjes Nick, et al.
Publicado: (2021)